Venus Remedies dispatches first batch of essential medicines to Ukraine

The company has launched a social media campaign to motivate people in India and abroad to make voluntary contributions for the cause

Venus Remedies
Press Trust of India Chandigarh
2 min read Last Updated : May 05 2022 | 2:38 PM IST

Leading research-driven pharmaceutical company Venus Remedies has dispatched the first batch of essential medicines worth USD 30,000 to Ukraine.

The company has also launched a social media campaign to motivate people in India and abroad to make voluntary contributions for the noble cause.

Venus Remedies employees have responded enthusiastically to the appeal by coming forward with donations in large numbers, as per a company statement.

"With millions of people bearing the brunt of this devastating war, it is a humanitarian crisis that calls for the need to rise to the occasion and reach out to Ukrainians with life-saving essential supplies," said Akshansh Chaudhary, President, HR, Venus Remedies, who flagged off the relief aid from the company's premises in Panchkula on April 28.

Appreciating the gesture, the Ukrainian Embassy in a statement issued on May 2, said that Venus Remedies has "proved that it is not only a business-oriented company but also a responsible organisation which has always stood firm for such noble causes to help people around the globe".

"We thank Venus Remedies for providing aid to the people of Ukraine in their most difficult times and readily accepting our request to supply us life-saving drugs free of cost," it said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Ukrainepharmaceutical firmsRussia Ukraine Conflict

First Published: May 05 2022 | 2:38 PM IST

Next Story